PSG1 for use in the treatment of osteoarthritis
AssigneeUniversity College Cork, National University of Ireland, Cork
InventorsTom Moore, Anthony James Peterson Clover
Life of this patent
Estimating the term…
Abstract
The use of Fc-tagged Pregnancy-specific glycoprotein 1 (PSG1-Fc) in a method of treatment of osteoarthritis or damaged cartilage in a human, in which the PSG1 is administered by intra-articular injection, is described. Also described is the use of CC49 in a method of treatment of osteoarthritis or damaged cartilage in an equine mammal, in which the CC49 is administered by intra-articular injection. (FIG. 3A-C) Also described is the use of PSG1 in a method of treatment of wounds, scarring, burns and diabetic ulcers in a mammal.
Claims6
A method of treatment of osteoarthritis or damaged cartilage in a human comprising administering a therapeutically effective amount of Pregnancy-specific glycoprotein 1 (PSG1) to the human, by intra-articular injection.
A method of treatment of osteoarthritis or damaged cartilage in an equine mammal comprising administering a therapeutically effective amount of CC49 to the equine mammal by intra-articular injection.
Dependencies are inferred from the claim text.